Milestone Pharmaceuticals (MIST) Share-based Compensation: 2018-2024
Historic Share-based Compensation for Milestone Pharmaceuticals (MIST) over the last 7 years, with Dec 2024 value amounting to $5.8 million.
- Milestone Pharmaceuticals' Share-based Compensation rose 8.51% to $2.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $9.0 million, marking a year-over-year increase of 24.30%. This contributed to the annual value of $5.8 million for FY2024, which is 39.42% down from last year.
- Latest data reveals that Milestone Pharmaceuticals reported Share-based Compensation of $5.8 million as of FY2024, which was down 39.42% from $9.5 million recorded in FY2023.
- In the past 5 years, Milestone Pharmaceuticals' Share-based Compensation registered a high of $9.5 million during FY2023, and its lowest value of $4.9 million during FY2020.
- In the last 3 years, Milestone Pharmaceuticals' Share-based Compensation had a median value of $9.0 million in 2022 and averaged $8.1 million.
- Per our database at Business Quant, Milestone Pharmaceuticals' Share-based Compensation soared by 315.20% in 2020 and then tumbled by 39.42% in 2024.
- Milestone Pharmaceuticals' Share-based Compensation (Yearly) stood at $4.9 million in 2020, then skyrocketed by 47.20% to $7.3 million in 2021, then rose by 24.30% to $9.0 million in 2022, then climbed by 5.37% to $9.5 million in 2023, then plummeted by 39.42% to $5.8 million in 2024.